News
Investegate |M.L. Laboratories Announcements | M.L. Laboratories: IB...
www.investegate.co.uk
Investegate announcements from M.L. Laboratories, IB License Agreement
Otsuka Announces Worldwide Access Plan for Delamanid with Stop TB...
www.informazione.it
"This agreement with the Stop TB Partnership is only the first step in assuring wider, equitable access to delamanid," said Masuhiro Yoshitake, managing director of Otsuka and TB Global Project leader. "Otsuka is committed to working with all stakeholders in the TB community to scale-up delamanid use in a rational way ...
Otsuka Receives Opinion from CHMP on Delamanid
www.finanznachrichten.de
Nachrichten » Otsuka Receives Opinion from CHMP on ... Otsuka Receives Opinion from CHMP on Delamanid strength of our filing," said Masuhiro Yoshitake, ...
CHMP Recommends Otsuka's Deltyba (delamanid) for EU Approval for...
www.finanznachrichten.de
Re-examination leads to positive opinion. If approved it would be the first new TB drug in Europe in more than 40 years. MDR-TB is an orphan disease in...
sortiert nach Relevanz / Datum